(Q42663942)

4 November 2017

Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice. I. Pindolol enantiomers and pindobind 5-HT1A. (English)

1 reference

4 November 2017

1 reference

Cao BJ

1

1 reference

PubMed ID

9300623

4 November 2017

Rodgers RJ

series ordinal

2

1 reference

PubMed ID

9300623

4 November 2017

language of work or name

English

0 references

publication date

1 October 1997

1 reference

Pharmacology, Biochemistry and Behavior

4 November 2017

1 reference

4 November 2017

58

1 reference

4 November 2017

583-591

1 reference

4 November 2017

2

1 reference

Preclinical pharmacology of FG5893: a potential anxiolytic drug with high affinity for both 5-HT1A and 5-HT2A receptors.

4 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

(-)-pindolol and (+/-)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Effects of pindobind 5-hydroxytryptamine1A (5-HT1A), a novel and potent 5-HT1A antagonist, on social and agonistic behaviour in male albino mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Effects of (-)-pindolol and SDZ 216-525 on social and agonistic behavior in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

5-Hydroxytryptamine release in dorsal hippocampus of freely moving rats: modulation by pindolol.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Anxiolytic-like profile of p-MPPI, a novel 5HT1A receptor antagonist, in the murine elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice. II. WAY 100635, SDZ 216-525 and NAN-190.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Metoprolol, a new selective beta-blocker in anxiety neurosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Evidence that RU 24969-induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5-HT1B receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Peripheral 5-carboxamidotryptamine induces hindlimb scratching by stimulating 5-HT1A receptors in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Species differences in the mechanism through which the serotonergic agonists indorenate and ipsapirone produce their anxiolytic action

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Evidence for the involvement of the 5-HT1A receptor in the anxiolytic action of indorenate and ipsapirone.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Action of ipsapirone and 8-OH-DPAT on exploratory behavior in hamsters (Mesocricetus auratus): effects of antagonists and p-CPA

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Anxiolytic effects in the plus-maze of 5-HT1A-receptor ligands in dorsal raphé and ventral hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

5-HT receptors: subtypes and second messengers

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Effect of metoprolol and diazepam on pre-operative anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Structural analysis by the comparative molecular field analysis method of the affinity of beta-adrenoreceptor blocking agents for 5-HT1A and 5-HT1B receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

WAY 100,135 and (-)-tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Characterization of a novel and potent 5-hydroxytryptamine1A receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Interaction of GABA and serotonin in the anxiolytic action of diazepam and serotonergic anxiolytics

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Behavioral profile of the 5HT1A receptor antagonist (S)-UH-301 in rodents and monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-1B agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Effects of beta-adrenoceptor ligands in the elevated X-maze 'anxiety' model and antagonism of the 'anxiogenic' response to 8-OH-DPAT.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Dihydroergosine: anticonflict effect in rats and enhancing effects on [3H]muscimol binding in the human brain post mortem.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

The role of hippocampal 5-hydroxytryptamine 1A (5-HT1A) receptors in the anticonflict activity of beta-adrenoceptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

The role of 5-hydroxytryptamine1A (5-HT1A) receptors in the anticonflict activity of beta-adrenoceptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Development of 5-HT1A receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white text box.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

The antiaggressive potency of (-)-penbutolol involves both 5-HT1A and 5-HT1B receptors and beta-adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Effect of twoβ-blockers on stress during mental arithmetic

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Behavioral and autonomic responses to intermittent social stress: differential protection by clonidine and metoprolol.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Molecular Basis of Buspirone's Anxiolytic Action

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Current status of beta-blocking drugs in the treatment of anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

Anxiolytics not acting at the benzodiazepine receptor: beta blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900280-3

7 January 2021

10.1016/S0091-3057(97)00280-3

Identifiers

DOI

1 reference

4 November 2017

1 reference

PubMed ID

9300623